e-Edition
Obituaries
Special Sections
Special Occasions
Contact

Subscribe
Paywall Login
Login to Comment
Register

December 11th, 2017

jobs

homes

Home
News
Sports
Business
Entertainment
Classifieds
Commentary

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Silence Therapeutics Plc - American Depository Share (NQ:SLN)

6.835 +0.035 (+0.51%)

Streaming Delayed Price Updated: 2:46 PM EDT, May 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Silence Therapeutics Plc - American Depository Share

< Previous 1 2 3 4 5 6 Next >

Silence Therapeutics Appoints J.P. Gabriel as Chief Technical Operations Officer

February 06, 2023

From Silence Therapeutics plc

Via Business Wire

Silence Therapeutics Provides SLN360 and SLN124 Clinical Program Updates

January 12, 2023

From Silence Therapeutics

Via Business Wire

Silence Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference

January 03, 2023

From Silence Therapeutics

Via Business Wire

Silence Therapeutics' Thalassemia Hopeful Shows Favorable Safety Profile In Early Stage Study ↗

September 29, 2022

Via Benzinga

Why Coupa Software Shares Jumped Around 29%; Here Are 72 Biggest Movers From Wednesday ↗

November 25, 2022

Gainers Kalera Public Limited Company (NASDAQ: KAL) jumped 76.9% to close at $0.1610 on Wednesday after gaining 9% on Tuesday. Kalera recently posted a Q3 loss of $0.05 per share.

Via Benzinga

Silence Therapeutics Reports Third Quarter 2022 Results

November 10, 2022

From Silence Therapeutics plc

Via Business Wire

Silence Therapeutics to Present at Jefferies London Healthcare Conference

November 09, 2022

From Silence Therapeutics plc

Via Business Wire

Silence Therapeutics Presents New Analysis from SLN360 Phase 1 Single Dose Study in High Lipoprotein(a) at the American Heart Association (AHA) 2022 Annual Meeting

November 05, 2022

From Silence Therapeutics plc

Via Business Wire

Silence Therapeutics Announces Preliminary Single Dose Results from SLN124 Phase 1 Study in Patients with Thalassemia

September 29, 2022

From Silence Therapeutics plc

Via Business Wire

Silence Therapeutics to Participate in Fireside Chat at Chardan Genetic Medicines Conference

September 27, 2022

From Silence Therapeutics plc

Via Business Wire

Important Biotech Catalysts For September 8, 2022 - End Of The Day Summary ↗

September 08, 2022

Via Benzinga

Silence Therapeutics Gets FDA Fast Track Status For Blood Cancer Candidate ↗

September 08, 2022

Silence Therapeutics (NASDAQ: SLN) announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to its lead candidate SLN124 for the treatment of polycythemia vera...

Via Benzinga

Silence Therapeutics to Participate in September Investment Conferences

September 08, 2022

From Silence Therapeutics plc

Via Business Wire

Silence Therapeutics Announces FDA Fast Track Designation for SLN124, a Novel Investigational siRNA Therapy for the Treatment of Polycythemia Vera

September 08, 2022

From Silence Therapeutics plc

Via Business Wire

Workday, Electronic Arts, Ulta Beauty And Some Other Big Stocks Moving Higher On Friday ↗

August 26, 2022

Micro Focus International plc (NYSE: MFGP) shares jumped 95.4% to $6.11 after the company reached an agreement with OpenText to be acquired for $6 billion.

Via Benzinga

Silence Therapeutics Announces Pricing of Underwritten Offering

August 11, 2022

From Silence Therapeutics plc

Via Business Wire

This Biotechnology Stock Tumbled 37%; Here Are 70 Biggest Movers From Yesterday ↗

August 19, 2022

Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares climbed 135.9% to close at $2.17 on Thursday.

Via Benzinga

Silence Therapeutics to Present at Jefferies Healthcare Conference

June 02, 2022

From Silence Therapeutics plc

Via Business Wire

Why Plus Therapeutics Is Trading Higher By Over 50%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session ↗

August 18, 2022

Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares jumped 297% to $3.66.

Via Benzinga

Silence Therapeutics to Participate in Fireside Chat at H.C. Wainwright Global Investment Conference

May 18, 2022

From Silence Therapeutics plc

Via Business Wire

76 Biggest Movers From Yesterday: Ocean Bio-Chem, Athira Pharma And More ↗

June 23, 2022

Gainers Ocean Bio-Chem, Inc. (NASDAQ: OBCI) shares climbed 117.2% to close at $12.86 on Wednesday after the company announced it will be acquired by OneWater Marine for $13.08 per share in cash.

Via Benzinga

Silence Therapeutics Reports First Quarter 2022 Results

May 16, 2022

From Silence Therapeutics plc

Via Business Wire

88 Biggest Movers From Yesterday ↗

May 26, 2022

Gainers The Very Good Food Company Inc. (NASDAQ: VGFC) shares jumped 118.2% to close at $0.2950 on Wednesday as the company announced it increased retail distribution across Canada with Loblaw...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

May 10, 2022

Via Benzinga

74 Biggest Movers From Yesterday ↗

April 29, 2022

Gainers T Stamp Inc. (NASDAQ: IDAI) shares surged 123.8% to close at $4.70 on Thursday. Trust Stamp reported the launch of its Biometric Multi-Factor Authentication (Biometric...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

April 28, 2022

Via Benzinga

61 Biggest Movers From Yesterday ↗

April 28, 2022

Gainers Vivakor, Inc. (NASDAQ: VIVK) shares jumped 113.5% to close at $3.65 on Wednesday after the company announced it has signed a 10-year contract with Hot Oil Transport with...

Via Benzinga

38 Stocks Moving In Wednesday's Mid-Day Session ↗

April 27, 2022

Gainers Vivakor, Inc. (NASDAQ: VIVK) gained 154% to $4.3550 after the company announced it has signed a 10-year contract with Hot Oil Transport with a potential value of...

Via Benzinga

Silence Therapeutics Achieves $2 Million Research Milestone in Hansoh Pharma Collaboration

April 25, 2022

From Silence Therapeutics plc

Via Business Wire

Silence Therapeutics to Present at 21st Annual Needham Virtual Healthcare Conference

April 06, 2022

From Silence Therapeutics plc

Via Business Wire

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

More ways to get to us

Facebook

Twitter

YouTube

ePaper Login
Subscribe
Subscription Services
Archive

About Us

The Lethbridge Herald
Other Publications
Food For Thought

Contact
Careers

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

Advertising
Terms and Conditions & Privacy Policy